Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Bulbo-Spinal Atrophy, X-Linked × 5'-ACCaagtttcttcAGC-3' × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1 Bulbo-Spinal Atrophy, X-Linked 1 Adenocarcinoma 1

Interventions

enzalutamide 2 abiraterone 2 ostarine 1 exemestane 1 darolutamide 1 Prednisolone 1 Docetaxel 1 AZD5305 1 AZD3514 1 5'-ACCaagtttcttcAGC-3' 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01337518 2012-12-18

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Enzon Pharmaceuticals, Inc.

Phase 1 Suspended

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon ⚡